News Detail
Lucknow, 6 Jan 2025: In a ray of hope for patients of triple negative breast cancer (TNBC), the scientists have found that administration of a drug on a specific enzyme found in the human body can help treat this most aggressive subtype of breast cancer.
"A......
View Details
Source : The Times of India
CSIR-Central Drug Research Institute
triple negative breast cancer
CDRI research
breast cancer treatment
ACSL4 enzyme
TNBC treatment
cancer metastasis
breast cancer research
new therapeutic strategies
Related News
- Three drug smugglers arrested with 5200 narcotic capsules in Abohar (07-01-2025)
- FDA warning letter reveals poor quality control, inadequate handling of manufacturing errors at Viatris plant in Pithampur (07-01-2025)
- CSIR developed indigenous technology for paracetamol manufacturing (07-01-2025)
- Medical device sales hit Rs 8039.63 crore under PLI scheme (07-01-2025)
- Six new biomarkers could transform kidney injury monitoring and treatment (07-01-2025)
- IPC raises alarm on adverse reaction caused by Beta- blocker drugs (07-01-2025)
- Police launch probe into two infants’ deaths, kin blame vaccine (07-01-2025)
- 'HMPV does not spread like Covid-19': Expert debunks myths, explains precautions needed to combat virus (07-01-2025)
- Extension of revised Schedule M deadline fails to bring total relief to MSMEs (07-01-2025)
- IIT Guwahati Advances Cholesterol and Triglyceride detection with Advanced Nanotechnology (07-01-2025)